Skin Burns Market Research Report present a detailed analysis of the market listing Skin Burns Epidemiology, Drug therapies and pipeline for study period from 2016-2018.

Skin Burns Market Research Report, Market Analysis, Market Growth, trends and Forecast

DelveInsight's 'Skin Burns- Market Insights, Epidemiology and Market Forecast-2028' report delivers an in-depth understanding of the disease, historical and forecasted epidemiology as well as the market trends of Skin Burns in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom), and Japan.
The Report provides the current treatment practices, emerging drugs, market share of the individual therapies, current and forecasted market size of Skin Burns from 2017 to 2028 segmented by seven major markets. The Report also covers current treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assess underlying potential of the market.
&nbsp;
<h2>Geography Covered</h2>
&bull; The United States
&bull; EU5 (Germany, France, Italy, Spain and the United Kingdom)
&bull; Japan
&nbsp;
<h2>Study Period: 2017-2028</h2>
&nbsp;
<h2>Skin Burns - Disease Understanding</h2>
The&nbsp;DelveInsight&rsquo;s&nbsp;Skin Burns market report gives a thorough understanding of the Skin Burns by including details such as disease definition, symptoms, causes, pathophysiology, diagnosis, and treatment.
Skin Burns Diagnosis
This segment of the report covers the detailed diagnostic methods or tests for Skin Burns.
Skin Burns Treatment
It covers the details of conventional and current medical therapies available in the Skin Burns market for the treatment of the condition. It also provides Skin Burns treatment algorithms and guidelines in the United States, Europe, and Japan.
<h2>Skin Burns Epidemiology</h2>
The Skin Burns epidemiology division provide the insights about historical and current patient pool and forecasted trend for every 7 major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the DelveInsight report also provides the diagnosed and treatable patient pool and their trends along with assumptions undertaken.
The disease epidemiology covered in the report is segmented by diagnosed incident population, hospitalized-visit incident population of Skin Burns, gender-specific diagnosed incident population and severity-specific diagnosed incident population and cause- specific diagnosed incident population of Skin Burns.
The DelveInsight report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.
According to DelveInsight, the incident population of Skin Burns was estimated to be 16,800 [7MM] in 2018. United States accounts for the highest skin-burn cases, followed by EU5 (Germany, France, Italy, Spain and UK) and Japan. Among the EU5 countries UK had the highest incident patient population of Skin Burns, followed France.
&nbsp;
<h2>Skin Burns Drug Chapters</h2>
This segment of the Skin Burns report encloses the detailed analysis of marketed drugs and late stage (Phase-III) pipeline drugs. It also helps to understand the clinical trial details, expressive pharmacological action, agreements and collaborations, approval and patent details, advantages and disadvantages of each included drug and the latest news and press releases.
The treatment regimen of skin burns is mainly classified according to the intensity of the impact and severity of the burn. Moisturizers, over the counter analgesics and /or anti-inflammatory agents, hydration and topical treatments (such as silver releasing agents). Although silver has been used in the form of salts such as Silver nitrate and silver sulfadiazine (Silvadene; King Pharmaceuticals, Inc.) since the past forty years, the available delivery systems often in the form of a salt have been limiting factors to successful biologic use of this noble metal in burn wound care. Xenografts introduce exogenous collagen into the wound, which aids dermal regeneration. Some of the commonly used products include Matriderm (Suwelack Skin and Health Care Ag) and Oasis (Healthpoint, Fort Worth). Second degree burns are treated with topical medications in superficial cases. However, for deep burn cases TransCyte (Advanced BioHealing, Inc.) is a dressing that is in use. The primary reason being that they impair fibroblast and epithelial proliferation, which in turn delays healing.
Detailed chapters for all of these drugs along with other marketed therapies have been covered in the report.
&nbsp;
<h2>Skin Burns Market Outlook</h2>
The Skin Burns market outlook of the report helps to build the detailed comprehension of the historic, current and forecasted trend of the market by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand of better technology.
This segment gives a through detail of market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on annual cost of therapy, inclusion and exclusion criteria's, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated market data are presented with relevant tables and graphs to give a clear view of the market at first sight.
According to DelveInsight, the global market of Skin Burns was estimated to be USD 1452.96 million in 2018. The United States accounts for the largest market size of Skin Burns, in comparison to EU5 (the United Kingdom, Germany, Italy, France, and Spain), and Japan. The most promising candidate which was recently approved by the US FDA is Avita Medical's RECELL System (RECELL Autologous Cell Harvesting Device). It is the first spray-on skin product to win approval for the U.S. market and is expected to transform the way burns are treated worldwide.
The dynamics of Skin Burns market is anticipated to change in the coming years owing to the expected launch of emerging therapies during the forecasted period 2019-2028. Key players are working robustly on new therapies with novel mechanism of action, including StrataGraft (Mallinckrodt), CellMist System (RenovaCare).
&nbsp;
<h2>Skin Burns Drugs Uptake</h2>
This section focusses on the rate of uptake of the potential drugs recently launched in the market or will get launched in the market during the study period from 2017-2028. The analysis covers market uptake by drugs; patient uptake by therapies and sales of each drug.
This helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allows the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.
Expected launch of potential therapies will lead to an increase in the market size of Skin Burns in the coming years.
&nbsp;
<h2>Skin Burns Report Insights</h2>
&bull; Patient Population
&bull; Therapeutic Approaches
&bull; Pipeline Analysis
&bull; Market Size and Trends
&bull; Market Opportunities
&bull; Impact of upcoming Therapies
&nbsp;
<h2>Skin Burns Report Key Strengths</h2>
&bull; 10 Year Forecast
&bull; 7MM Coverage
&bull; Epidemiology Segmentation
&bull; Drugs Uptake
&bull; Highly Analyzed Market
&bull; Key Cross Competition
&nbsp;
<h2>Skin Burns Report Assessment</h2>
&bull; Current Treatment Practices
&bull; Unmet Needs
&bull; Detailed Pipeline Product Profiles
&bull; Market Attractiveness
&bull; Market Drivers and Barriers
&nbsp;
<h2>Key Benefits</h2>
&bull; This DelveInsight report will help to develop Business Strategies by understanding the trends shaping and driving the Skin Burns market.
&bull; Organize sales and marketing efforts by identifying the best opportunities for Skin Burns market.
&bull; To understand the future market competition in the Skin Burns market.

1 Key Insights2 Skin Burns Market Overview at a Glance2.1 Market Share (%) Distribution of Skin Burns in 20172.2 Market Share (%) Distribution of Skin Burns in 20283 Disease Background and Overview3.1 Introduction3.2 Classification3.3 Signs and Symptoms3.4 Pathophysiology3.5 Mechanism involved in Burn-Induced Microvascular Inflammation3.6 Diagnosis3.6.1 American Burn Association Burn Unit Referral Criteria3.7 Diagnostic Approach to Skin Burns3.7.1 Japanese Dermatological Association: Wound/Burn Guidelines4 Epidemiology and Patient Population4.1 Key Findings5 7MM Total Prevalent Patient Population of Skin Burns6 Country Wise-Epidemiology of Skin Burns7 United States7.1 Assumptions and Rationale7.2 Total Incident Cases of Skin Burns in the United States7.3 Total Hospitalized Visit Cases of Skin Burns in the United States7.4 Incident Cases of Skin Burns by Severity in the United States7.5 Incident Cases of Skin Burns by Cause in the United States7.6 Incident Cases of Skin Burns by Gender in the United States8 EU58.1 Assumptions and Rationale9 Germany9.1 Total Incident Cases of Skin Burns in Germany9.2 Total Hospitalized Visit Cases of Skin Burns in Germany9.3 Incident Cases of Skin Burns by Severity in Germany9.4 Incident Cases of Skin Burns by Cause in Germany9.5 Incident Cases of Skin Burns by Gender in Germany10 France10.1 Total Incident Cases of Skin Burns in France10.2 Total Hospitalized Visit Cases of Skin Burns in France10.3 Incident Cases of Skin Burns by Severity in France10.4 Incident Cases of Skin Burns by Cause in France10.5 Incident Cases of Skin Burns by Gender in France11 Italy11.1 Total Incident Cases of Skin Burns in Italy11.2 Total Hospitalized Visit Cases of Skin Burns in Italy11.3 Incident Cases of Skin Burns by Severity in Italy11.4 Incident Cases of Skin Burns by Cause in Italy11.5 Incident Cases of Skin Burns by Gender in Italy12 Spain12.1 Total Incident Cases of Skin Burns in Spain12.2 Total Hospitalized Visit Cases of Skin Burns in Spain12.3 Incident Cases of Skin Burns by Severity in Spain12.4 Incident Cases of Skin Burns by Cause in Spain12.5 Incident Cases of Skin Burns by Gender in Spain13 United Kingdom13.1 Total Incident Cases of Skin Burns in the United Kingdom13.2 Total Hospitalized Visit Cases of Skin Burns in the United Kingdom13.3 Incident Cases of Skin Burns by Severity in the United Kingdom13.4 Incident Cases of Skin Burns by Cause in the United Kingdom13.5 Incident Cases of Skin Burns by Gender in the United Kingdom14 Japan14.1 Assumptions and Rationale14.2 Total Incident Cases of Skin Burns in Japan14.3 Total Hospitalized Visit Cases of Skin Burns in Japan14.4 Incident Cases of Skin Burns by Severity in Japan14.5 Incident Cases of Skin Burns by Cause in Japan14.6 Incident Cases of Skin Burns by Gender in Japan15 Treatment of Skin Burns15.1.1 Emergency Management15.1.2 Specific Treatment15.2 WHO Guidelines for Management of Burns15.2.1 Burn Management in Adults15.2.2 Burn Management in Children15.2.3 Depth of burn15.2.4 Wound Care15.3 NHS Guidelines on the Initial Assessment &amp; Management of Burn-Injured Patients15.3.1 Assessment &amp; Management of Imminently Life-Threatening Problems15.3.2 Assessment of the Burn Wound15.3.3 Intravenous Fluid Resuscitation15.3.4 Smoke Inhalation Injury15.3.5 Burn Wound Management15.3.6 Analgesia15.3.7 Referral to a Specialised Burns Service15.3.8 Transfer to a Specialised Burns Service15.4 Japanese Dermatological Association: Wound/Burn Guidelines15.5 Therapeutic Algorithm for Local Burn Wound16 Unmet Needs17 Marketed Therapies17.1 Topical Treatments: Antimicrobials, Antibiotics, and others17.2 Silvadene: Pfizer17.2.1 Drug Description17.2.2 Regulatory Milestones17.2.3 Other Developmental Activities17.3 Skin Substitutes17.3.1 Temporary Skin Substitutes17.3.2 Permanent Skin Substitutes17.4 “Spray-On Skin” Therapy17.5 Recell: Avita Medical17.5.1 Product Description17.5.2 Regulatory Milestones18 Emerging Therapies18.1 Key cross competition- Emerging Therapies18.2 StrataGraft: Mallinckrodt18.2.1 Product Description18.2.2 Other Development Activities18.2.3 Clinical Development18.2.4 Safety and Efficacy18.2.5 Product Profile18.3 SkinGun (CellMist System): RenovaCare18.3.1 Product Description18.3.2 Other Development Activities18.3.3 Clinical Development18.3.4 Safety and Efficacy18.3.5 Product Profile19 Skin Burns: 7 Major Market Analysis19.1 Key Findings19.2 Total Market Size of Skin Burns in 7MM19.1 7 MM Size of Skin Burns by Therapies20 Market Outlook by Country21 The United States: Market Outlook21.1 United States Market Size21.1.1 Total Market size of Skin Burns in the United States21.1.2 Skin Burns Market By therapies22 EU-5 Countries: Market Outlook22.1 Germany Market Size22.1.1 Total Market size of Skin Burns in Germany22.1.2 Skin Burns Market By therapies22.2 France Market Size22.2.1 Total Market size of Skin Burns in France22.2.2 Skin Burns Market By therapies22.3 Italy Market Size22.3.1 Total Market size of Skin Burns in Italy22.3.2 Skin Burns Market By therapies22.4 Spain Market Size22.4.1 Total Market size of Skin Burns in Spain22.4.2 Skin Burns Market By therapies22.5 The United Kingdom Market Size22.5.1 Total Market size of Skin Burns in the United Kingdom22.5.2 Skin Burns Market By therapies23 Japan: Market Outlook23.1 Japan: Market Size23.1.1 Total Market size of Skin Burns in Japan23.1.2 Skin Burns Market By therapies24 Market Drivers25 Market Barriers26 Appendix26.1 Report Methodology27 DelveInsight Capabilities28 Disclaimer29 About DelveInsight

Skin Burns - Market Insight, Epidemiology and Market Forecast - 2028

DelveInsight's 'Skin Burns - Market Insights, Epidemiology and Market Forecast-2028' report delivers an in-depth understanding of the disease, historical & forecasted epidemiology..